Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety and Efficacy of Remote Ischemic Conditioning for the Treatment of Diabetic Kidney Disease: a Single-center Double-blinded Randomized Controlled Study

NCT06654921 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.

NCT NCT06654921
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06654921 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety and Efficacy of Remote Ischemic Conditioning for the Treatment of Diabetic Kidney Disease: a Single-center Double-blinded Randomized Controlled Study
Lead sponsor
Capital Medical University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
January 31, 2025
Completion date
December 31, 2025
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic kidney disease (dkd)